Mapping the UK’s Emergency Use of Nasal High-Flow Therapy
A recent service-level survey of all UK adult emergency departments (EDs) reveals the current state of nasal high-flow (NHF) therapy implementation. Conducted in early 2025, the survey aimed to understand access, clinical indications, and perceived barriers to NHF use for conditions like type-1 respiratory failure. The findings highlight that while NHF is increasingly adopted as a non-invasive respiratory support tool, its integration into standard ED practice across the UK is not yet uniform, with variations in availability and application protocols.
Why it might matter to you: For critical care professionals, this national survey provides a crucial snapshot of real-world adoption for a key non-invasive ventilation alternative. Understanding current usage patterns and perceived barriers can inform your own unit’s protocols for managing acute respiratory failure and guide decisions on equipment allocation and staff training. The data underscores the ongoing shift in emergency airway and respiratory management, directly relevant to optimizing patient flow from the ED to the ICU.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
